Labeling of Nonprescription Human Drug Products Marketed Without an Approved Application as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act: Questions and Answers
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 1, 2009
January 19, 2023
ab547dc3-9724-4072-b1cd-f90728d300e3
Related Documents
Postmarketing Adverse Event Reporting for Nonprescription Human Drug Products Marketed Without an Approved Application
Guidance DocumentJuly 17, 2009Center for Drug Evaluation and Research
Radioactive Drug Research Committee: Human Research Without An Investigational New Drug Application
Guidance DocumentAugust 2, 2010Center for Drug Evaluation and Research
Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims
Guidance DocumentMarch 15, 2011Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.